Multi District Litigation

MDL 3026

In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation
- Chief Judge Rebecca R. Pallmeyer

MDL 3026
In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation
- Chief Judge Rebecca R. Pallmeyer



ENTER MEMORANDUM Opinion and Order Signed by the Honorable Rebecca R. Pallmeyer on 6/23/2022.Mailed notice(mjc, ) (Entered: 06/23/2022)


MEMORANDUM Opinion and Order: Signed by the Honorable Rebecca R. Pallmeyer on 8/22/2022. Mailed notice. (cp, ) (Entered: 08/22/2022)


MEMORANDUM Opinion and Order: Signed by the Honorable Rebecca R. Pallmeyer on 8/29/2022. Mailed notice.(cp, ) (Entered: 08/29/2022)


MEMORANDUM Opinion and Order: For the foregoing reasons in the Memorandum Opinion and Order, Plaintiffs' motions to remand are granted. Signed by the Honorable Rebecca R. Pallmeyer on 10/12/2022. Mailed notice. (cp, ) (Entered: 10/13/2022)


ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 10/12/2022. Mailed notice. (cp, ) (Entered: 10/13/2022)


Plaintiffs’ Co-Lead Counsel 
Timothy J. Becker
C. Andrew Childers
Wendy R. Fleishman
José M. Rojas
Diandra “Fu” Debrosse Zimmermann

Plaintiffs’ Executive Committee
David P. Matthews
James R. Ronca
Matthew J. Sill
Ashlie Case Sletvold
Diane K. Watkins

Plaintiffs’ Steering Committee
Russell T. Abney
Annesley DeGaris
Gerald J. Diaz, Jr.
Deborah S. Dixon
James R. Dugan, II
Kelly Hyman
Kristine K. Kraft
Noah C. Lauricella
Christopher T. Nace
Ellen A. Presby
Stephen Reck
Pearl A. Robertson
John F. Romano
James M. Williams
Jeffrey A. Bowersox

Plaintiffs’ Liaison Counsel
Elizabeth A. Kaveny


Abbott’s Lead Counsel
Stephanie E. Parker

Abbott’s Co-Liaison Counsel
Meir Feder
Bridget K. O’Connor

Mead Johnson’s Lead Counsel
Rachel Cannon

Mead Johnson’s Co-Liaison Counsel
Darlene Alt
William Andrichik


What is multidistrict litigation?

Multidistrict litigation is litigation pending in more than one federal district court involving common questions of fact. When such cases involve civil actions, they may be transferred by the Judicial Panel on Multidistrict Litigation (The Panel) to any federal court for coordinated and consolidated pretrial proceedings.

What is the Panel on multidistrict litigation?

The panel is a group of seven federal judges designated by the Chief Justice of the United States. The Panel has the responsibility for determining which cases qualify for multidistrict litigation treatment, as well as which district court to transfer and consolidate these cases. The transfers are made pursuant to 28 U.S.C. §1407, upon the Panel's determination that the transfers will result in the convenience of the parties and witnesses and will promote the just and efficient conduct of the cases.

How are the cases to be transferred brought before the Panel?

Proceedings for transfer may be initiated by the Judicial Panel on Multidistrict Litigation upon its own initiative or a motion filed with the Panel by a party in any action in which transfer for coordinated or consolidated pretrial proceedings may be appropriate. Before cases are designated multidistrict litigation and transferred to one federal court, the Panel convenes a hearing and notifies all parties of the place and time of the hearing. The Panel's order of transfer is based on a record of such hearing at which material evidence may be offered by any party to an action in any federal court that would be affected by the transfer.

If my case is subject to a transfer order, but the case has not yet been transferred to the Northern District of Illinois, where should I file documents?

Transfers under 28 U.S.C. §1407 become effective with the filing of the Panel's transfer order in the clerk's office of the designated transferee court. Thus, if the transfer order to which your case is subject has been filed in the Northern District of Illinois, you must make all future filings in the Northern District of Illinois.

Does the Court permit direct filing of cases in the Northern District of Illinois when venue is in another district?

To be determined.

Do I need to file a motion in the Northern District of Illinois to appear pro hac vice or do I need to associate local counsel?

Pro hac vice requirements (and the payment of associated fees) are waived for any attorney who has filed an appearance in a transferor court. Attorneys admitted to practice and in good standing in any United States District Court may be admitted pro hac vice in this litigation without the payment of the pro hac vice fee and without associating with local counsel. Whether or not they file appearances in this case, all lawyers in this litigation are expected to comply with the Court's Local Rules and to abide by the terms of the case management orders and protective orders.

Are attorneys in this MDL required to be e-filers in the Northern District of Illinois?

Yes. Any attorney who will participate actively in the litigation and wishes to receive copies of court filings must file an appearance in this Court and register as an e-filer, receiving training, if he/she is not registered as an e-filer in this Court or another federal court. See General Order 16-0020.

Are there any special procedures regarding service?

__________________has been authorized to accept service of Summons and Complaint on behalf of any defendants pursuant to Fed R. Civ. P. 4(d). See Case Management Order No. 1 (34)

Is there a form complaint that should be filed?

Do I need to submit courtesy copies of all electronic filings?

According to the Fifth Amended General Order, courtesy copies are no longer required and motions shall not be noticed for presentment. Parties shall propose a briefing schedule on opposed motions by joint submission to the court.

 How can I be kept advised of the developments of this case?

Court orders, developments, and upcoming events will be posted on the Court's website.

How can I access the docket sheet?

You may access the docket sheet online by purchasing a PACER account through the PACER Service Center's website at .

Does the Court permit telephone participation at status conferences?

Yes, in some instances.


Chief Judge Rebecca R. Pallmeyer, U.S. District Judge

Courthouse Address
219 South Dearborn Street
Chicago, Illinois  60604

Courtroom Deputy
Christina Presslak
(312) 435-5637
Room 2528A

Judicial Assistant
Susan Kelly Lenburg
(312) 435-5600
Room 2548

Court Reporter
Frances Ward
(312) 435-5561
Room 2524A
Order Transcript:

Please note that Ms. Ward will not respond immediately to orders for transcripts as she is in court most of the day. If you order a transcript, you may assume that she is preparing it and will contact you when your transcript is complete and ready for pick-up.

Case #PlaintiffDefendantOrig. District Case #Originating DistrictDate Closed
1:22-cv-00071HallAbbott Laboratories
1:22-cv-00192RinehartAbbott Laboratories2022L000293Circuit Court of Cook County, Illinois
1:22-cv-00197GshwendAbbott Laboratories2022L000297Circuit Court of Cook County
1:22-cv-00203TaylorAbbott Laboratories2022L000301Cook County, IL County Department, Law Division
1:22-cv-00204StuperAbbott Laboratories2022L000299Circuit Court of Cook County06/23/2022
1:22-cv-00232MarAbbott Laboratories
1:22-cv-00239RhodesAbbott Laboratories
1:22-cv-00363GrosshueschMead Johnson & Company, LLC3:21-cv-01461Illinois Southern
1:22-cv-00561ShindelAbbott Laboratories
1:22-cv-01089De Los SantosAbbott Laboratories
1:22-cv-01197DevineAbbott Laboratories, Inc.07/22/2022
1:22-cv-01439FelicianoAbbott Laboratories, Inc.
1:22-cv-01951CresapAbbott Laboratories
1:22-cv-01987RichardsonAbbott Laboratories, Inc.2:21-cv-09932California Central
1:22-cv-01989DavisAbbott Laboratories, Inc.5:21-cv-00481California Central
1:22-cv-01991KeltonAbbott Laboratories, Inc.5:21-cv-02145California Central
1:22-cv-01994LittlesAbbott Laboratories, Inc.5:21-cv-02146California Central
1:22-cv-01995HunteAbbott Laboratories, Inc.3:20-cv-01626Connecticut
1:22-cv-01996GeorgeAbbott Laboratories, Inc.1:20-cv-02537District of Columbia
1:22-cv-01997Sanchez JuanAbbott Laboratories, Inc.6:21-cv-00502Florida Middle
1:22-cv-01998CrawfordMead Johnson & Company1:21-cv-00201Florida Northern
1:22-cv-02001BrownAbbott Laboratories, Inc.3:21-cv-00687Louisiana Middle
1:22-cv-02002ChildsAbbott Laboratories1:22-cv-00711District of Columbia09/19/2022
1:22-cv-02003PerkinsAbbott Laboratories, Inc.2:22-cv-00658Louisiana Eastern09/19/2022
1:22-cv-02004WalkerAbbott Laboratories, Inc.3:22-cv-00174Louisiana Middle09/19/2022
1:22-cv-02005AdamsAbbott Laboratories2:22-cv-00036Mississippi Southern09/19/2022
1:22-cv-02006ClarkeAbbott Laboratories4:22-cv-00144Missouri Eastern
1:22-cv-02007OsmunAbbott Laboratories3:22-cv-05018Missouri Western
1:22-cv-02008BookhartAbbott Laboratories, Inc.4:22-cv-00032Missouri Western
1:22-cv-02010LincolnAbbott Laboratories, Inc.4:22-cv-00033Missouri Western09/19/2022
1:22-cv-02011R.J.Mead Johnson & Company, LLC4:22-cv-00147Missouri Western
1:22-cv-02013HughesAbbott Laboratories, Inc.4:22-cv-00157Missouri Western01/18/2023
1:22-cv-02014PostonAbbott Laboratories, Inc.4:22-cv-00158Missouri Western
1:22-cv-02015SilversAbbott Laboratories, Inc.4:22-cv-00159Missouri Western09/19/2022
1:22-cv-02016MedleyAbbott Laboratories, Inc.2:22-cv-00273Nevada
1:22-cv-02017KoethMead Johnson & Company, LLC.2:22-cv-00350Nevada
1:22-cv-02018McKinnonMead Johnson & Company, LLC2:22-cv-00422Nevada
1:22-cv-02019PayneAbbott Laboratories4:22-cv-00230Texas Southern
1:22-cv-02022CervantesMead Johnson & Company LLC11/10/2022
1:22-cv-02081AcostaAbbott Laboratories09/19/2022
1:22-cv-02202WilliamsMead Johnson & Company, LLC09/19/2022
1:22-cv-02203MoiseMead Johnson & Company, LLC09/19/2022
1:22-cv-02206HighsmithMead Johnson & Company, LLC
1:22-cv-02222JacobsAbbott Laboratories, Inc.
1:22-cv-02257M. R.Mead Johnson & Company, LLC
1:22-cv-02300DeleonMead Johnson & Company LLC11/10/2022
1:22-cv-02498GoalAbbott Laboratories09/19/2022
1:22-cv-02510Nancy Doty, Inc.Abbott Laboratories3:22-cv-00635Oregon
1:22-cv-02511AbdullahMead Johnson & Company2:22-cv-01684Pennsylvania Eastern10/14/2022
1:22-cv-02513DraytonMead Johnson & Company, LLC2:22-cv-01687Pennsylvania Eastern10/14/2022
1:22-cv-02515StillsMead Johnson & Company, LLC2:22-cv-01691Pennsylvania Eastern10/14/2022
1:22-cv-02516CarterMead Johnson & Company, LLC2:22-cv-01700Pennsylvania Eastern10/14/2022
1:22-cv-02517TaylorMead Johnson & Company, LLC2:22-cv-01703Pennsylvania Eastern10/14/2022
1:22-cv-02518WeigerMead Johnson & Company, LLC2:22-cv-01712Pennsylvania Eastern10/14/2022
1:22-cv-02519WiegerMead Johnson & Company, LLC2:22-cv-01713Pennsylvania Eastern10/14/2022
1:22-cv-02553Pinckney-WhiteAbbott Laboratories Inc.
1:22-cv-02569SmithAbbott Laboratories, Inc.
1:22-cv-02610MeltonAbbott Laboratories Inc.4:22-cv-00109Georgia Southern10/12/2022
1:22-cv-02611Henderson Mead Johnson & Company, LLC2:22-cv-01721Pennsylvania Eastern10/14/2022
1:22-cv-02612HInesMead Johnson & Company, LLC2:22-cv-01722Pennsylvania Eastern10/14/2022
1:22-cv-02613JOHNSONMEAD JOHNSON & COMPANY, LLC2:22-cv-01724Pennsylvania Eastern10/14/2022
1:22-cv-02614McMillianMead Johnson & Company, LLC2:22-cv-01725Pennsylvania Eastern10/14/2022
1:22-cv-02615Moment Mead Johnson & Company LLC2:22-cv-01737Pennsylvania Eastern10/14/2022
1:22-cv-02616Walker-SavageAbbott Laboratories2:22-cv-01740Pennsylvania Eastern10/14/2022
1:22-cv-02617SandersMead Johnson & Company LLC2:22-cv-01742Pennsylvania Eastern10/14/2022
1:22-cv-02618ShortMead Johnson & Company, LLC2:22-cv-01745Pennsylvania Eastern10/14/2022
1:22-cv-02619WhitfieldMead Johnson & Company, LLC et al2:22-cv-01746Pennsylvania Eastern10/14/2022
1:22-cv-02620ThomasMead Johnson & Company LLC2:22-cv-01749Pennsylvania Eastern10/14/2022
1:22-cv-02621WilliamsMead Johnson & Company, LLC2:22-cv-01750Pennsylvania Eastern10/14/2022
1:22-cv-02623WitherspoonMead Johnson & Company, LLC2:22-cv-01752Pennsylvania Eastern10/14/2022
1:22-cv-02712GoodmondMead Johnson & Company, LLC2:22-cv-01782Pennsylvania Eastern10/14/2022
1:22-cv-02713GoodmondMead Johnson & Company, LLC2:22-cv-01786Pennsylvania Eastern10/14/2022
1:22-cv-02714GrayMead Johnson & Company, LLC2:22-cv-01806Pennsylvania Eastern10/14/2022
1:22-cv-02716KajuffaMead Johnson & Company LLC2:22-cv-01809Pennsylvania Eastern10/14/2022
1:22-cv-02719MaysMead Johnson & Company LLC2:22-cv-01828Pennsylvania Eastern10/14/2022
1:22-cv-02720PadillaMead Johnson & Company, LLC2:22-cv-01831Pennsylvania Eastern10/14/2022
1:22-cv-02729HumphreysAbbott Laboratories3:22-cv-00146Tennessee Eastern09/15/2022
1:22-cv-02760ParkerMead Parker Johnson & Company, LLC2:22-cv-01840Pennsylvania Eastern10/14/2022
1:22-cv-02761RossMead Johnson & Company, LLC2:22-cv-01850Pennsylvania Eastern10/14/2022
1:22-cv-02762WigginsMead Johnson & Company, LLC2:22-cv-01873Pennsylvania Eastern10/14/2022
1:22-cv-02763WatsonMead Johnson & Company, LLC et al2:22-cv-01874Pennsylvania Eastern10/14/2022
1:22-cv-02829HammannAbbott Laboratories, Inc.04/21/2023
1:22-cv-02891AndradeAbbott Laboratories, Inc.5:22-cv-02780California Northern
1:22-cv-02893SmithAbbott Laboratories, Inc.5:22-cv-02794California Northern
1:22-cv-02895Chazmine Lindsey and Bernard FoleyAbbott Laboratories1:22-cv-01815Georgia Northern
1:22-cv-02896Lambert-EllisAbbott Laboratories, Inc.0:22-cv-01289Minnesota
1:22-cv-02897BembryAbbott Laboratories Inc5:22-cv-00392Oklahoma Western
1:22-cv-02898LeakAbbott Laboratories Inc2:22-cv-00624Washington Western
1:22-cv-03016Chazmine Lindsey and Bernard FoleyAbbott Laboratories1:22-cv-01815Georgia Northern
1:22-cv-03054ThomasAbbott Laboratories Inc.3:22-cv-02971California Northern
1:22-cv-03055HiattAbbott Laboratories Inc2:22-cv-00915California Eastern
1:22-cv-03056KahanAbbott Laboratories, Inc.1:22-cv-03134New York Eastern
1:22-cv-03057MejiaAbbott Laboratories, Inc.3:22-cv-00159Texas Southern
1:22-cv-03136DensonMead Johnson & Company, LLC2022L005309Circuit Court of Cook County Illinois06/17/2022
1:22-cv-03152LollarMead Johnson & Company, LLC2:22-cv-00165Texas Eastern
1:22-cv-03325LopezAbbott Laboratories, Inc.
1:22-cv-03589VickersMead Johnson & Company, LLC1:22-cv-00773California Eastern10/21/2022
1:22-cv-03590HarrellAbbott Laboratories4:22-cv-03761California Northern08/31/2022
1:22-cv-03591Patton-AshleyAbbott Laboratories, Inc.1:22-cv-01520Colorado03/16/2023
1:22-cv-03649HughesAbbott Laboratories
1:22-cv-03737InmanMead Johnson & Company, LLC3:22-cv-00086Indiana Southern
1:22-cv-03794McCarthyAbbott Laboratories, Inc.
1:22-cv-03807HagermanAbbott Laboratories1:22-cv-01190Ohio Northern
1:22-cv-04115ParianiMead Johnson & Company, LLC2:22-cv-00723California Eastern08/31/2022
1:22-cv-04116LafondMead Johnson & Company, LLC2:22-cv-00724California Eastern08/31/2022
1:22-cv-04117ThomasMead Johnson & Company, LLC4:22-cv-02460California Northern08/31/2022
1:22-cv-04118TracyMead Johnson & Company, LLC4:22-cv-02480California Northern08/31/2022
1:22-cv-04120HartwickMead Johnson & Company, LLC4:22-cv-02598California Northern08/31/2022
1:22-cv-04179AlexanderMead Johnson & Company, LLC3:22-cv-00812Illinois Southern
1:22-cv-04316DeJesusAbbott Laboratories1:22-cv-06306New York Southern10/17/2022
1:22-cv-04318MeierAbbott Laboratories3:22-cv-00411Wisconsin Western
1:22-cv-04616AnthonyAbbott Laboratories, Inc.3:22-cv-00336North Carolina Western
1:22-cv-04849ChapinAbbott Laboratories
1:22-cv-04853ChobirkoAbbott Laboratories
1:22-cv-05029J.N.Abbott Laboratories, Inc.
1:22-cv-05033WilliamsAbbott Laboratories
1:22-cv-05044WalkerMead Johnson & Company, LLC
1:22-cv-05045WillisAbbott Laboratories
1:22-cv-05048CashAbbott Laboratories, Inc.
1:22-cv-05053K.M.Abbott Laboratories, Inc.
1:22-cv-05059DelpilarAbbott Laboratories
1:22-cv-05061SinclairAbbott Laboratories, Inc.
1:22-cv-05062IzziAbbott Laboratories
1:22-cv-05064EscobarAbbott Laboratories Inc.
1:22-cv-05169BushAbbott Laboratories2:22-cv-03221Louisiana Eastern
1:22-cv-05355OdomAbbott Laboratories2:22-cv-03310Louisiana Eastern
1:22-cv-05356DiggsAbbott Laboratories1:22-cv-02356Maryland
1:22-cv-05365GippAbbott Laboratories
1:22-cv-05623PitreMead Johnson & Company, LLC3:22-cv-00646Louisiana Middle
1:22-cv-05626CornwellAbbott Laboratories3:22-cv-00654Louisiana Middle
1:22-cv-05627HillMead Johnson & Co LLC3:22-cv-05239Louisiana Western
1:22-cv-05639GoalAbbott Laboratories4:22-cv-00952Arkansas Eastern
1:22-cv-05735BrownAbbott Laboratories
1:22-cv-05812BonnerAbbott Laboratories1:22-cv-00127Missouri Eastern
1:22-cv-05813GilliamMead Johnson & Company LLC3:22-cv-05825New Jersey
1:22-cv-05816PaulAbbott Laboratories
1:22-cv-05982PeeblesMead Johnson & Company, LLC3:22-cv-00652Louisiana Middle
1:22-cv-06027MoyeAbbott Laboratories
1:22-cv-06405E.M.Mead Johnson & Company, LLC3:22-cv-02533Illinois Southern
1:22-cv-06594KeaneAbbott Laboratories
1:22-cv-06623TurnerAbbott Laboratories
1:22-cv-06673GrandersonAbbott Laboratories3:22-cv-00669Mississippi Southern
1:22-cv-06898KortusAbbott Laboratories
1:22-cv-06909GonzalesMead Johnson & Company, LLC
1:22-cv-06914RoddyAbbott Laboratories
1:22-cv-07084CarterAbbott Laboratories1:22-cv-04759Georgia Northern
1:22-cv-07085LiddellAbbott Laboratories2:22-cv-04765Louisiana Eastern
1:22-cv-07086CatheyAbbott Laboratories1:22-cv-01018North Carolina Middle
1:22-cv-07123LockmanAbbott Laboratories
1:22-cv-07130MillerMead Johnson & Company, LLC2:22-cv-04766Louisiana Eastern
1:22-cv-07229BakerAbbott Laboratories Inc
1:22-cv-07302SheppardAbbott Laboratories Inc.1:22-cv-04861Georgia Northern
1:22-cv-07303TorresAbbott Laboratories, et. al.3:22-cv-00450Texas Western
1:22-cv-07342EmilcaMead Johnson & Company, LLC9:22-cv-81907Florida Southern
1:23-cv-00153LewisAbbott Laboratories2:22-cv-02151Arizona
1:23-cv-00154CoffmanMead Johnson and Company2:22-cv-00971New Mexico
1:23-cv-00200CrossAbbott Laboratories
1:23-cv-00209KeyAbbott Laboratories
1:23-cv-00229W.C.Mead Johnson & Company, LLC
1:23-cv-00263PalmatureMead Johnson & Company, LLC
1:23-cv-00294PhamAbbott Laboratories4:23-cv-00007Texas Southern
1:23-cv-00316CervantesAbbott Laboratories, Inc.
1:23-cv-00323FirlitAbbott Laboratories
1:23-cv-00324DeleonAbbott Laboratories, Inc.
1:23-cv-00331KendallAbbott Laboratories, Inc.
1:23-cv-00481LucasMead Johnson & Company, LLC2:23-cv-00121Louisiana Eastern
1:23-cv-00550SinghAbbott Laboratories1:23-cv-00055Indiana Southern
1:23-cv-00551NazzaroAbbott Laboratories, Inc.2:23-cv-00162New Jersey
1:23-cv-00581MasonAbbott Laboratories, INC
1:23-cv-00671WyattMead Johnson & Company, LLC
1:23-cv-00990AustinAbbott Laboratories3:23-cv-00182Ohio Northern
1:23-cv-00992ZapataMead Johnson & Company, LLC2023L000527The Circuit Court Of Cook County
1:23-cv-01156RoweAbbott Laboratories
1:23-cv-01161SilversAbbott Laboratories1:22-cv-00071In Re: Abbott Laboratories, et al.,
1:23-cv-01191JohnsonAbbott Laboratories8:23-cv-00257Florida Middle
1:23-cv-01249SmithMead Johnson Laboratories
1:23-cv-01252BrownAbbott Laboratories
1:23-cv-01259CummingMead Johnson & Company, LLC
1:23-cv-01306NesheimMead Johnson & Co. LLC
1:23-cv-01412HammannAbbott Laboratories
1:23-cv-01422E.D.Abbott Laboratories, Inc.
1:23-cv-01491Lincoln, Individually and as Mother and General GuAbbott Laboratories1:22-cv-00071In Re: Abbott Laboratories, et al.,
1:23-cv-01547JeffersonAbbott Laboratories
1:23-cv-01549DryeAbbott Laboratories1:23-cv-00769Georgia Northern
1:23-cv-01550RamseyAbbott Laboratories Inc3:23-cv-00217Louisiana Western
1:23-cv-01555JosephMead Johnson & Company, LLC1:23-cv-00465Georgia Northern
1:23-cv-01556MarcelMead Johnson & Company, LLC1:23-cv-00596New York Eastern
1:23-cv-01642CoulombeAbbott Laboratories1:23-cv-10474Massachusetts
1:23-cv-01643RunyonMead Johnson & Company, LLC3:23-cv-00008Tennessee Eastern
1:23-cv-01648ScrbacicAbbott Laboratories, Inc.
1:23-cv-01770HernandezMead Johnson & Company, LLC et al
1:23-cv-01785GammageAbbott Laboratories
1:23-cv-01816StevensonMead Johnson & Company, LLC3:23-cv-00831Illinois Southern
1:23-cv-01830SanchezMead Johnson & Company, LLC
1:23-cv-01831PersleyMead Johnson & Company LLC
1:23-cv-01832VillaroelMead Johnson & Company LLC
1:23-cv-01833GaydenMead Johnson & Company LLC
1:23-cv-01860CamachoMead Johnson & Company, LLC2023L001498The Circuit Court of Cook County, Illinois
1:23-cv-01869JohnsonMead Johnson & Company LLC
1:23-cv-01871TaylorMead Johnson & Company LLC
1:23-cv-01872WilderMead Johnson & Company LLC
1:23-cv-01873BonnerMead Johnson & Company LLC
1:23-cv-01881DumasMead Johnson & Company, LLC
1:23-cv-01882WoodruffMead Johnson & Company, LLC
1:23-cv-01908PeerAbbott Laboratories
1:23-cv-01919JohnsonAbbott Laboratories
1:23-cv-01937McIntyreAbbott Laboratories
1:23-cv-01966MyersMead Johnson & Company, LLC
1:23-cv-01973MitchellMead Johnson & Company LLC
1:23-cv-01974ThorpeMead Johnson & Company, LLC
1:23-cv-01976TurenneMead Johnson & Company LLC
1:23-cv-01979BrownMead Johnson & Company LLC
1:23-cv-01986BrunsonMead Johnson & Company LLC
1:23-cv-02068HesterMead Johnson Laboratories
1:23-cv-02077VelascoMead Johnson & Company, LLC3:23-cv-00865Illinois Southern
1:23-cv-02078CheramieMead Johnson & Company, LLC3:23-cv-00866Illinois Southern
1:23-cv-02104ZisaAbbott Laboratories
1:23-cv-02224De RuvoAbbott Laboratories
1:23-cv-02269LamendolaAbbott Laboratories
1:23-cv-02352Berry-BaptisteAbbott Laboratories Inc.0:23-cv-60529Florida Southern
1:23-cv-02353McGinnisAbbott Laboratories Inc.1:23-cv-21075Florida Southern
1:23-cv-02385CloveyAbbott Laboratories1:23-cv-02416New York Eastern
1:23-cv-02496GendronAbbott Laboratories
1:23-cv-02505LaneAbbott Laboratories1:23-cv-10740Massachusetts
1:23-cv-02507WoodsAbbott Laboratories
1:23-cv-02510ClarkMead Johnson & Company LLC
1:23-cv-02574FriedbauerMead Johnson Laboratories
1:23-cv-02584ValerioAbbott Laboratories
1:23-cv-02613DicksMead Johnson Laboratories
1:23-cv-02633TurnerMEAD JOHNSON & COMPANY, LLC
1:23-cv-02773MaldonadoAbbott Laboratories3:23-cv-00509Connecticut
1:23-cv-02914LeachMead Johnson Laboratories, Inc.
1:23-cv-03022SkowAbbott Laboratories
1:23-cv-03121GehringMead Johnson & Company, LLC
1:23-cv-03168OmalleyMead Johnson & Company, LLC
1:23-cv-03310RoccoAbbott Laboratories
1:23-cv-03386HoganAbbott Laboratories2:23-cv-01609Louisiana Eastern
1:23-cv-03388JonesMead Johnson & Company, LLC2:23-cv-01610Louisiana Eastern
1:23-cv-03396WallaceAbbott Laboratories

idDate PostedDoc.#Description
204/26/202234CASE MANAGEMENT ORDER NO. 1 Signed by the Honorable Rebecca R. Pallmeyer on 4/26/2022. Mailed notice(mjc, ) (Entered: 04/26/2022)
305/20/2022100MINUTE entry before the Honorable Rebecca R. Pallmeyer: Video Status hearing held on 5/19/2022. The court will rule promptly on competing proposals for designation of Lead and Liaison counsel and expects, as well, to set up a webpage for this MDL on the Court's website. A further status hearing is set for 6/30/22 at 10:00 a.m. to take place in person at the U. S. District Court, 219 South Dearborn, Chicago IL 60604. The parties will submit proposals regarding pretrial procedures, identifying disagreements, if any, no later than 6./17/2022. The court anticipates prompt consideration of pending motions for remand of removed cases. Mailed notice (mjc, ) (Entered: 05/20/2022)
406/02/2022109CASE MANAGEMENT ORDER NO. 2. Signed by the Honorable Rebecca R. Pallmeyer on 5/26/2022. Mailed notice(mjc, ) (Entered: 05/26/2022)
508/10/2022172CASE MANAGEMENT ORDER NO. 3: Disputes Regarding Privilege Order, Protective Order, and Master Complaint: Signed by the Honorable Rebecca R. Pallmeyer on 8/10/2022. Mailed notice. (cp, ) (Entered: 08/10/2022)
608/18/2022187CASE MANAGEMENT ORDER NO. 4, Rule 502(d) and Privileged Materials Order: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/18/2022)
708/18/2022188CASE MANAGEMENT ORDER NO. 5, STIPULATED PROTECTIVE ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/18/2022)
808/18/2022189CASE MANAGEMENT ORDER NO. 6, AGREED JOINT COORDINATION ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/18/2022)
908/18/2022190CASE MANAGEMENT ORDER NO. 7, Protocol for Selection of Initial Bellwether Discovery Cases and Initial Bellwether Trial Cases, and Authorization of Plaintiff Profile Forms: Signed by the Honorable Rebecca R. Pallmeyer on 8/18/2022. Mailed notice. (cp, ) (Entered: 08/19/2022)
1008/25/2022200CASE MANAGEMENT ORDER NO. 8: COMMON BENEFIT ORDER TIMEKEEPING AND EXPENSES PROTOCOL: Signed by the Honorable Rebecca R. Pallmeyer on 8/25/2022. Mailed notice. (cp, ) (Entered: 08/25/2022)
1308/26/2022204ORDER on Request for Master Complaint: Signed by the Honorable Rebecca R. Pallmeyer on 8/26/2022. Mailed notice. (cp, ) (Entered: 08/26/2022)
1109/07/2022210AMENDED CASE MANAGEMENT ORDER NO. 7: Protocol for Selection of Initial Bellwether Discovery Cases and Initial Bellwether Trial Cases, and Authorization of Plaintiff Profile Forms. Signed by the Honorable Rebecca R. Pallmeyer on 9/7/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D) Mailed notice. (cp, ) (Entered: 09/08/2022)
1209/07/2022211CASE MANAGEMENT ORDER NO. 9: Jurisdictional Discovery and Briefing Schedule. Signed by the Honorable Rebecca R. Pallmeyer on 9/7/2022. Mailed notice. (cp, ) (Entered: 09/08/2022)
1409/27/2022232AMENDED CASE MANAGEMENT ORDER NO. 8: COMMON BENEFIT ORDER Timekeeping and Expenses Protocol: Signed by the Honorable Rebecca R. Pallmeyer on 9/27/2022. Mailed notice. (Attachments: # 1 Exhibit Monthly Time Report, # 2 Exhibit Monthly Time Report Totals, # 3 Exhibit Expense Report, # 4 Exhibit Supplemental Expense Report, # 5 Exhibit NEC Participation Agreement)(cp, ) (Entered: 09/27/2022)
1510/22/2022266MINUTE entry before the Honorable Rebecca R. Pallmeyer: Oral argument on Defendants' motion for scientific presentations 239 and Defendants' motion to compel 261 are set for 11/4/2022 at 11:00 a.m. via Webex video conference. Counsel of record will receive an email invitation prior to the start of the video. Members of the public and media will be able to call in to listen to this hearing. The call in number is: 650-479-3207 and access code is: 2316 722 9487. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (cp, ) (Entered: 10/20/2022)
1710/26/2022268THE PARTIES' JOINT STIPULATED ORDER regarding the protocol for producing documents and electronically stored information ("ESI"): Signed by the Honorable Rebecca R. Pallmeyer on 10/26/2022. Mailed notice. (cp, ) (Entered: 10/27/2022)
1611/03/2022274CASE MANAGEMENT ORDER NO. 10 APPROVING PLAINTIFF FACT SHEET: Signed by the Honorable Rebecca R. Pallmeyer on 11/3/2022. Mailed notice. (cp, ) (Entered: 11/03/2022)
1811/22/2022281ORDER signed by the Honorable Rebecca R. Pallmeyer on 11/22/2022: In its November 11, 2022 order, this court provided guidance with respect to the parties' disputes regarding a discovery schedule and directed them to make a further attempt to agree on a proposed schedule. Counsel report that their effort to reach accord was unsuccessful. For reasons explained earlier, the court concludes that the schedule proposed by the Plaintiffs' Leadership Committee is reasonably aggressive, and hereby adopts that schedule as set forth in the attached Order. This schedule is subject to adjustment only for good cause shown or by good faith agreement of counsel. Counsel are encouraged to continue efforts to coordinate the schedule in this MDL with schedule[s] set by state court judges. A further status hearing is set for December 13, 2022, as previously ordered. Lead counsel are again invited to advise the courtroom deputy whether an in-person proceeding, or a meeting by video platform, is preferable.
1912/01/2022282ORDER PURSUANT TO CMO 7 Identifying Initial Bellwether Discovery Cases Selected By Defendants: Signed by the Honorable Rebecca R. Pallmeyer on 12/1/2022. Mailed notice. (cp, ) (Entered: 12/01/2022)
2001/06/202329501/06/2023 295 ORDER: Pursuant to stipulation of the Plaintiffs' Leadership Committee and Counsel for Defendants 294 , the January 9, 2023 status date is stricken, and a further case schedule is established as set forth below. The court will conduct a further status hearing on February 1, 2023 at 9:00 a.m. Central Standard Time. The court will conduct a Science Day hearing beginning at 9:30 a.m. Central Standard Time on March 8, 2023. See attached Order for further details. Signed by the Honorable Rebecca R. Pallmeyer on 1/6/2023. Mailed notice. (cp, ) (Entered: 01/06/2023)
2101/06/2023296CASE MANAGEMENT ORDER NO. 11 - DIRECT FILING ORDER: Signed by the Honorable Rebecca R. Pallmeyer on 1/6/2023. Mailed notice. (cp, ) (Entered: 01/06/2023)

05/11/2022 67 ORDER SETTING AGENDA FOR MAY 12, 2022 STATUS CONFERENCE Signed by the Honorable Rebecca R. Pallmeyer on 5/11/2022.
06/30/2022 144 Proposed Agenda by Rebecca Donaldson, Shannon E. Hall (Debrosse Zimmermann, Diandra) (Entered: 06/30/2022)
08/17/2022 181 Proposed Agenda for August 18, 2022 Status Hearing by Abbott Laboratories (Parker, Stephanie) (Entered: 08/17/2022)
10/07/2022 245 Proposed Agenda for October 11, 2022 Status Hearing by Abbott Laboratories (Parker, Stephanie) (Entered: 10/07/2022)
12/12/2022 285 Proposed Agenda for December 13, 2022 Status Hearing by Abbott Laboratories (Parker, Stephanie) (Entered: 12/12/2022)
04/03/2023 342 Proposed Agenda for April 4, 2023 Status Hearing by Abbot Laboratories (Parker, Stephanie) (Entered: 04/03/2023)
The status hearing set for February 1, 2023 is hereby stricken. A further status hearing is set for 1:00 p.m. on February 10, 2023.

WebEx Access Information

WebEx, with a call-in number of 1-650-479-3207 and access code 23040381197. To join the conference by WebEx video, counsel of record and members of the public can join by clicking on the following hyperlink:

Telephone Hearing Access Information

Please click on the below hyperlink  to take you to Judge Pallmeyer's telephone conference login. From there, join conference As Guest, Enter your name, Type the digits in the picture, Click on the Call Me option and fill in your phone number and name.  You will receive a call and be connected to the conference line. While participants will have the ability to identify who is speaking, speakers should still identify themselves for the purpose of creating a clear record. Participants should be careful to speak clearly and not to speak over any other participants.  If you do not have access to a computer Dial: TELEPHONE NUMBER.

Click here to join the conference:

If the above link does not work, please call: (877)336-1839 or (636)651-0008, access and security code: 6708061#.


view 277

MINUTE entry before the Honorable Rebecca R. Pallmeyer: Case management conference held on 11/4/2022, via Webex Video. The next status hearing is set for 12/13/2022 at 11:00 a.m. Lead counsel on both sides are invited to advise the courtroom deputy whether this hearing should be conducted in person or by video platform. Order to enter. Mailed notice. (cp, ) (Entered: 11/14/2022)
In person status hearing is set for 10/11/2022 at 10:00 a.m. at the U. S. District Court, 219 South Dearborn, Chicago IL 60604 in courtroom 2541.